ProPhase Labs (PRPH) P/E (2012 - 2026)
ProPhase Labs (PRPH) P/E from Apr 2, 2012 to Jul 21, 2026. The TTM ProPhase Labs (PRPH) P/E is -0.01. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of ProPhase Labs (PRPH)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.01 | -84.40% |
| 2025 | -0.03 | -90.36% |
| 2024 | -0.35 | -95.30% |
| 2023 | -7.45 | -256.58% |
| 2022 | 4.76 | -81.75% |
| 2021 | 26.05 | -175.13% |
| 2020 | -34.68 | +327.89% |
| 2019 | -8.10 | -732.32% |
| 2018 | 1.28 | +48.05% |
| 2017 | 0.87 | -94.80% |
| 2016 | 16.65 | +33.33% |
| 2015 | 12.49 | +2.74% |
| 2014 | 12.15 | -70.88% |
| 2013 | 41.73 | -421.07% |
| 2012 | -13.00 | N/A |
Comparison ProPhase Labs (PRPH) P/E with competitors
ProPhase Labs (PRPH) P/E is -0.01.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -20031.34% |
| MBAI | CheckCap Ltd | 1.71 | -32657.37% |
| FONR | Fonar Corp | 15.48 | -294329.13% |
| QGEN | Qiagen NV | 20.03 | -380852.24% |
| DGX | Quest Diagnostics Inc | 22.47 | -427301.67% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -453871.08% |
| IQV | IQVIA Holdings Inc | 25.28 | -480708.53% |
| A | Agilent Technologies Inc | 26.96 | -512553.05% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -599441.14% |
| MTD | Mettler-Toledo International Inc | 32.45 | -616958.28% |
| MEDP | Medpace Holdings Inc | 32.55 | -618849.72% |
| DHR | Danaher Corp | 38.55 | -732970.65% |
| IDXX | Idexx Laboratories Inc | 40.58 | -771405.72% |
| ILMN | Illumina Inc | 44.12 | -838780.68% |
| RVTY | Revvity Inc | 52.68 | -1001525.71% |
| VCYT | Veracyte Inc | 53.71 | -1021120.58% |
| ICLR | Icon Plc | 57.45 | -1092204.27% |
| SHC | Sotera Health Company | 74.08 | -1408387.33% |
| WAT | Waters Corp | 102.79 | -1953981.34% |